Pilocytic Astrocytoma — Trials

Pilocytic Astrocytoma — Trials · CancerIndex

Clinical trials

Registered studies

21 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01553149	Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma	completed	Phase 2	75	National Cancer Institute (NCI)NIH	4	Jan 7, 2025	clinicaltrials
NCT02684058	Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors	completed	Phase 2	151	Novartis PharmaceuticalsINDUSTRY	20	Dec 13, 2023	clinicaltrials
NCT00112736	Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma	completed	Phase 1 / Phase 2	69	National Cancer Institute (NCI)NIH	1	Jun 15, 2015	clinicaltrials

Data updated 22 days agoSource updated Jan 7, 2025source: clinicaltrials